ProMetic Life Sciences News
Most Popular ProMetic Life Sciences Story
Abraxis, ProMetic ink $295M deal for four drugs
Abraxis has signed a $295M licensing deal with ProMetic Life Sciences to develop and market four biotech drugs. The companies didn't say which programs they woud be collaborating on, only that the... Read more...
Latest Headlines
- September 5, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
